Prison-based harm reduction measures as part of hepatitis C virus treatment

Affiliations

¹ Behaviours and Health Risks Program, Public Health Discipline, Burnet Institute, Melbourne, VIC 3004, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Monash Addiction Research Centre, Monash University, Melbourne, VIC, Australia. Electronic address: michael.curtis@burnet.edu.au.
² Behaviours and Health Risks Program, Public Health Discipline, Burnet Institute, Melbourne, VIC 3004, Australia; Department of Public Health, La Trobe University, Bundoora, VIC, Australia.
³ Behaviours and Health Risks Program, Public Health Discipline, Burnet Institute, Melbourne, VIC 3004, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Comment

Michael Curtis et al. Lancet Gastroenterol Hepatol. 2019 Dec.

. 2019 Dec;4(12):903.

doi: 10.1016/S2468-1253(19)30335-8.

¹ Behaviours and Health Risks Program, Public Health Discipline, Burnet Institute, Melbourne, VIC 3004, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Monash Addiction Research Centre, Monash University, Melbourne, VIC, Australia. Electronic address: michael.curtis@burnet.edu.au.
² Behaviours and Health Risks Program, Public Health Discipline, Burnet Institute, Melbourne, VIC 3004, Australia; Department of Public Health, La Trobe University, Bundoora, VIC, Australia.
³ Behaviours and Health Risks Program, Public Health Discipline, Burnet Institute, Melbourne, VIC 3004, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

No abstract available

Comment on

Access to hepatitis C care for people who inject drugs and people in prisons.
Oru E, Verster A. Oru E, et al. Lancet Gastroenterol Hepatol. 2019 Sep;4(9):662-663. doi: 10.1016/S2468-1253(19)30201-8. Epub 2019 Jul 27. Lancet Gastroenterol Hepatol. 2019. PMID: 31362917 No abstract available.